LEONCINI LORENZO

Teaching activities

Completion accademic year: 2024/2025

Course year: 2 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2023/2024

Completion accademic year: 2023/2024

Course year: 2 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2022/2023

Completion accademic year: 2022/2023

Course year: 1 Rheumatology A.Y. 2022/2023
Course year: 2 Second cycle degree (Laurea Magistrale) MEDICAL BIOTECHNOLOGIES A.Y. 2021/2022
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2019/2020
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2019/2020

Completion accademic year: 2021/2022

Course year: 1 Rheumatology A.Y. 2021/2022
Course year: 1 GINECOLOGIA ED OSTETRICIA A.Y. 2021/2022

Research

Ultime pubblicazioni:

  • Maroui, M.A., Odongo, G.A., Mundo, L., Manara, F., Mure, F., Fusil, F., et al. (2024). Aflatoxin B1 and Epstein–Barr virus-induced CCL22 expression stimulates B cell infection. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 121(16) [10.1073/pnas.2314426121]. - view more
  • Leopizzi, M., Mundo, L., Messina, E., Campolo, F., Lazzi, S., Angeloni, A., et al. (2024). Epstein-Barr virus-encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma. BLOOD, 143(5), 429-443 [10.1182/blood.2023021346]. - view more
  • Ross, A.M., Leahy, C.I., Neylon, F., Steigerova, J., Flodr, P., Navratilova, M., et al. (2023). Epstein-Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma. LIFE, 13(2), 1-18 [10.3390/life13020521]. - view more
  • Granai, M., Lazzi, S., Mancini, V., Akarca, A., Santi, R., Vergoni, F., et al. (2022). Burkitt lymphoma with granulomatous reaction: A M1/TH1-polarized microenvironment associates with controlled growth and spontaneous regression. HISTOPATHOLOGY, 80(2), 430-442 [10.1111/his.14391]. - view more
  • Siciliano, M.C., Tornambè, S., Cevenini, G., Sorrentino, E., Granai, M., Giovannoni, G., et al. (2022). EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative. INFECTIOUS AGENTS AND CANCER, 17(1), 1-12 [10.1186/s13027-022-00469-5]. - view more